Lysosomes and oxidative stress in aging and apoptosis

Biochimica et Biophysica Acta - General Subjects

Volumn 1780, Issue 11, 2008, Pages 1291-1303

  Kurz, Tino ^a   Terman, Alexei ^a   Gustafsson, Bertil ^b   Brunk, Ulf T ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aging; Autophagy; Iron; Lipofuscin; Mitochondria; Oxidative stress

Indexed keywords

HYDROGEN PEROXIDE; IRON; LIPOFUSCIN;

AGING; APOPTOSIS; AUTOPHAGY; CELL DEATH; CELL FUNCTION; CELL VACUOLE; DIFFUSION; HUMAN; IRON METABOLISM; LYSOSOME; MACROMOLECULE; MITOCHONDRION; MITOSIS; NONHUMAN; OXIDATIVE STRESS; PHAGOSOME; PRIORITY JOURNAL; REVIEW; STARVATION; TRANS GOLGI NETWORK;

AGING; ANIMALS; APOPTOSIS; HUMANS; IRON; LYSOSOMES; MITOSIS; OXIDATIVE STRESS;

EID: 49349090381     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2008.01.009     Document Type: Review

References (123)

1. de Duve C. The lysosome turns fifty. Nat. Cell Biol. 7 (2005) 847-849
2. Brunk U., and Ericsson J.L. Electron microscopical studies on rat brain neurons. Localization of acid phosphatase and mode of formation of lipofuscin bodies. J. Ultrastruct. Res. 38 (1972) 1-15
3. Dunn Jr. W.A. Studies on the mechanisms of autophagy: maturation of the autophagic vacuole. J. Cell Biol. 110 (1990) 1935-1945
4. Brunk U. Distribution and shifts of ingested marker particles in residual bodies and other lysosomes. Studies on in vitro cultivated human glia cells in phase II and 3. Exp. Cell Res. 79 (1973) 15-27
5. Kiselyov K., Jennigs Jr. J.J., Rbaibi Y., and Chu C.T. Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy 3 (2007) 259-262
6. Settembre C., Fraldi A., Jahreiss L., Spampanato C., Venturi C., Medina D., Pablo R.D., Tacchetti C., Rubinsztein D.C., and Ballabio A. A block of autophagy in lysosomal storage disorders. Hum. Mol. Genet. 17 (2008) 119-129
7. Terman A. The effect of age on formation and elimination of autophagic vacuoles in mouse hepatocytes. Gerontology 41 (1995) 319-326
8. Terman A., and Brunk U.T. The aging myocardium: roles of mitochondrial damage and lysosomal degradation. Heart Lung Circ. 14 (2005) 107-114
9. de Duve C. Lysosomes, a new group of cytoplasmic particles. In: Hayashi T. (Ed). Subcellular Particles (1959), The Ronald Press Co., New York 128-159
10. Brunk U.T., and Ericsson J.L. Cytochemical evidence for the leakage of acid phosphatase through ultrastructurally intact lysosomal membranes. Histochem. J. 4 (1972) 479-491
11. Brunk U.T., Neuzil J., and Eaton J.W. Lysosomal involvement in apoptosis. Redox Rep. 6 (2001) 91-97
12. Cirman T., Oresic K., Mazovec G.D., Turk V., Reed J.C., Myers R.M., Salvesen G.S., and Turk B. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J. Biol. Chem. 279 (2004) 3578-3587
13. Glaumann H., Ericsson J.L., and Marzella L. Mechanisms of intralysosomal degradation with special reference to autophagocytosis and heterophagocytosis of cell organelles. Int. Rev. Cytol. 73 (1981) 149-182
14. Shintani T., and Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 306 (2004) 990-995
15. Yorimitsu T., and Klionsky D.J. Autophagy: molecular machinery for self-eating. Cell Death Differ. 12 (2005) 1542-1552
16. Cuervo A.M., Bergamini E., Brunk U.T., Droge W., Ffrench M., and Terman A. Autophagy and aging: the importance of maintaining "clean" cells. Autophagy 1 (2005) 131-140
17. Suzuki K., and Ohsumi Y. Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. FEBS Lett. 581 (2007) 2156-2161
18. Semenza G.L., Artemov D., Bedi A., Bhujwalla Z., Chiles K., Feldser D., Laughner E., Ravi R., Simons J., Taghavi P., and Zhong H. 'The metabolism of tumours': 70 years later. Novartis Found. Symp. 240 (2001) 251-260
19. Bartrons R., and Caro J. Hypoxia, glucose metabolism and the Warburg's effect. J. Bioenerg. Biomembr. 39 (2007) 223-229
20. Luzio J.P., Pryor P.R., and Bright N.A. Lysosomes: fusion and function. Nat. Rev., Mol. Cell Biol. 8 (2007) 622-632
21. Martinez-Zaguilan R., Lynch R.M., Martinez G.M., and Gillies R.J. Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am. J. Physiol. 265 (1993) C1015-C1029
22. Montcourrier P., Silver I., Farnoud R., Bird I., and Rochefort H. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism. Clin. Exp. Metastasis 15 (1997) 382-392
23. De Milito A., and Fais S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol. 1 (2005) 779-786
24. Lorenzo K., Ton P., Clark J.L., Coulibaly S., and Mach L. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor. Cancer Res. 60 (2000) 4070-4076
25. Rochefort H., Capony F., and Garcia M. Cathepsin D: a protease involved in breast cancer metastasis. Cancer Metastasis Rev. 9 (1990) 321-331
26. Podgorski I., and Sloane B.F. Cathepsin B and its role(s) in cancer progression. Biochem. Soc. Symp. (2003) 263-276
27. Victor B.C., and Sloane B.F. Cysteine cathepsin non-inhibitory binding partners: modulating intracellular trafficking and function. Biol. Chem. 388 (2007) 1131-1140
28. Terman A., Gustafsson B., and Brunk U.T. Autophagy, organelles and ageing. J. Pathol. 211 (2007) 134-143
29. Klionsky D.J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev., Mol. Cell Biol. 8 (2007) 931-937
30. Cuervo A.M., Palmer A., Rivett A.J., and Knecht E. Degradation of proteasomes by lysosomes in rat liver. Eur. J. Biochem. 227 (1995) 792-800
31. Kaushik S., and Cuervo A.M. Autophagy as a cell-repair mechanism: activation of chaperone-mediated autophagy during oxidative stress. Mol. Aspects Med. 27 (2006) 444-454
32. Bergamini E. Autophagy: a cell repair mechanism that retards ageing and age-associated diseases and can be intensified pharmacologically. Mol. Aspects Med. 27 (2006) 403-410
33. Miyawaki H. Histochemistry and electron microscopy of iron-containing granules, lysosomes, and lipofuscin in mouse mammary glands. J. Natl. Cancer Inst. 34 (1965) 601-623
34. Brun A., and Brunk U. Histochemical indications for lysosomal localization of heavy metals in normal rat brain and liver. J. Histochem. Cytochem. 18 (1970) 820-827
35. Schraufstätter I., Hyslop P.A., Jackson J.H., and Cochrane C.G. Oxidant-induced DNA damage of target cells. J. Clin. Invest. 82 (1988) 1040-1050
36. Sakaida I., Kyle M.E., and Farber J.L. Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress. Mol. Pharmacol. 37 (1990) 435-442
37. Zdolsek J.M., Roberg K., and Brunk U.T. Visualization of iron in cultured macrophages: a cytochemical light and electron microscopic study using autometallography. Free Radic. Biol. Med. 15 (1993) 1-11
38. Radisky D.C., and Kaplan J. Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts. Biochem. J. 336 (1998) 201-205
39. Roberts S., and Bomford A. Ferritin iron kinetics and protein turnover in K562 cells. J. Biol. Chem. 263 (1988) 19181-19187
40. Vaisman B., Fibach E., and Konijn A.M. Utilization of intracellular ferritin iron for hemoglobin synthesis in developing human erythroid precursors. Blood 90 (1997) 831-838
41. Kurz T., Terman A., and Brunk U.T. Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron. Arch. Biochem. Biophys. 462 (2007) 220-230
42. Nilsson E., Ghassemifar R., and Brunk U.T. Lysosomal heterogeneity between and within cells with respect to resistance against oxidative stress. Histochem. J. 29 (1997) 857-865
43. Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat. Res. 531 (2003) 81-92
44. Zhang A.S., Sheftel A.D., and Ponka P. Intracellular kinetics of iron in reticulocytes: evidence for endosome involvement in iron targeting to mitochondria. Blood 105 (2005) 368-375
45. Richardson D.R. Therapeutic potential of iron chelators in cancer therapy. Adv. Exp. Med. Biol. 509 (2002) 231-249
46. Takagi H., Shi D., Ha Y., Allewell N.M., and Theil E.C. Localized unfolding at the junction of three ferritin subunits. A mechanism for iron release?. J. Biol. Chem. 273 (1998) 18685-18688
47. Liu X., Jin W., and Theil E.C. Opening protein pores with chaotropes enhances Fe reduction and chelation of Fe from the ferritin biomineral. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3653-3658
48. De Domenico I., Vaughn M.B., Li L., Bagley D., Musci G., Ward D.M., and Kaplan J. Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J. 25 (2006) 5396-5404
49. Tenopoulou M., Doulias P.T., Barbouti A., Brunk U., and Galaris D. Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis. Biochem. J. 387 (2005) 703-710
50. Kidane T.Z., Sauble E., and Linder M.C. Release of iron from ferritin requires lysosomal activity. Am. J. Physiol., Cell Physiol. 291 (2006) 445-455
51. Koorts A.M., and Viljoen M. Ferritin and ferritin isoforms I: structure-function relationships, synthesis, degradation and secretion. Arch. Physiol. Biochem. 113 (2007) 30-54
52. Jolly R.D., Douglas B.V., Davey P.M., and Roiri J.E. Lipofuscin in bovine muscle and brain: a model for studying age pigment. Gerontology 41 (1995) 283-295
53. Brunk U.T., and Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic. Biol. Med. 33 (2002) 611-619
54. Pisoni R.L., Acker T.L., Lisowski K.M., Lemons R.M., and Thoene J.G. A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: possible role in supporting lysosomal proteolysis. J. Cell Biol. 110 (1990) 327-335
55. Schafer F.Q., and Buettner G.R. Acidic pH amplifies iron-mediated lipid peroxidation in cells. Free Radic. Biol. Med. 28 (2000) 1175-1181
56. Baird S.K., Kurz T., and Brunk U.T. Metallothionein protects against oxidative stress-induced lysosomal destabilization. Biochem. J. 394 (2006) 275-283
57. Walton J.H., and Lewis H.A. The partition coefficients of hydrogen peroxide between water and certain organic solvents. J. Am. Chem. Soc. 38 (1916) 633-638
58. Eaton J.W., and Qian M. Molecular bases of cellular iron toxicity. Free Radic. Biol. Med. 32 (2002) 833-840
59. Terman A., and Brunk U.T. Lipofuscin: mechanisms of formation and increase with age. APMIS 106 (1998) 265-276
60. Turk B., Stoka V., Rozman-Pungercar J., Cirman T., Droga-Mazovec G., Oresic K., and Turk V. Apoptotic pathways: involvement of lysosomal proteases. Biol. Chem. 383 (2002) 1035-1044
61. 2 is a consequence of lysosomal rupture. Biochem. J. 356 (2001) 549-555
62. Garner B., Li W., Roberg K., and Brunk U.T. On the cytoprotective role of ferritin in macrophages and its ability to enhance lysosomal stability. Free Radic. Res. 27 (1997) 487-500
63. Garner B., Roberg K., and Brunk U.T. Endogenous ferritin protects cells with iron-laden lysosomes against oxidative stress. Free Radic. Res. 29 (1998) 103-114
64. Persson H.L., Nilsson K.J., and Brunk U.T. Novel cellular defenses against iron and oxidation: ferritin and autophagocytosis preserve lysosomal stability in airway epithelium. Redox Rep. 6 (2001) 57-63
65. Viarengo A., Burlando B., Ceratto N., and Panfoli I. Antioxidant role of metallothioneins: a comparative overview. Cell. Mol. Biol. 46 (2000) 407-417
66. Arosio P., and Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic. Biol. Med. 33 (2002) 457-463
67. Terman A., Gustafsson B., and Brunk U.T. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem. Biol. Interact. 163 (2006) 29-37
68. Pandolfo M. Iron and Friedreich ataxia. J. Neural Transm., Suppl. (2006) 143-146
69. Berg D., and Youdim M.B. Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 17 (2006) 5-17
70. Miyajima H. Aceruloplasminemia, an iron metabolic disorder. Neuropathology 23 (2003) 345-350
71. Fontenay M., Cathelin S., Amiot M., Gyan E., and Solary E. Mitochondria in hematopoiesis and hematological diseases. Oncogene 25 (2006) 4757-4767
72. Sipe J.C., Lee P., and Beutler E. Brain iron metabolism and neurodegenerative disorders. Dev. Neurosci. 24 (2002) 188-196
73. de Duve C., and Wattiaux R. Functions of lysosomes. Annu. Rev. Physiol. 28 (1966) 435-492
74. Kroemer G., and Jäättelä M. Lysosomes and autophagy in cell death control. Nat. Rev. Cancer 5 (2005) 886-897
75. Brunk U.T., Dalen H., Roberg K., and Hellquist H.B. Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic. Biol. Med. 23 (1997) 616-626
76. Kågedal K., Zhao M., Svensson I., and Brunk U.T. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 359 (2001) 335-343
77. Boya P., Andreau K., Poncet D., Zamzami N., Perfettini J.L., Metivier D., Ojcius D.M., Jäättelä M., and Kroemer G. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J. Exp. Med. 197 (2003) 1323-1334
78. Ohkuma S., and Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. U. S. A. 75 (1978) 3327-3331
79. Li W., Yuan X.M., Ivanova S., Tracey K.J., Eaton J.W., and Brunk U.T. 3-Aminopropanal, formed during cerebral ischaemia, is a potent lysosomotropic neurotoxin. Biochem. J. 371 (2003) 429-436
80. Yu Z., Li W., and Brunk U.T. 3-Aminopropanal is a lysosomotropic aldehyde that causes oxidative stress and apoptosis by rupturing lysosomes. APMIS 111 (2003) 643-652
81. Guicciardi M.E., Leist M., and Gores G.J. Lysosomes in cell death. Oncogene 23 (2004) 2881-2890
82. Nylandsted J., Gyrd-Hansen M., Danielewicz A., Fehrenbacher N., Lademann U., Hoyer-Hansen M., Weber E., Multhoff G., Rohde M., and Jäättelä M. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J. Exp. Med. 200 (2004) 425-435
83. Zhao M., Antunes F., Eaton J.W., and Brunk U.T. Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. Eur. J. Biochem. 270 (2003) 3778-3786
84. Barbouti A., Amorgianiotis C., Kolettas E., Kanavaros P., and Galaris D. Hydrogen peroxide inhibits caspase-dependent apoptosis by inactivating procaspase-9 in an iron-dependent manner. Free Radic. Biol. Med. 43 (2007) 1377-1387
85. Bidere N., Lorenzo H.K., Carmona S., Laforge M., Harper F., Dumont C., and Senik A. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem. 278 (2003) 31401-31411
86. Heinrich M., Neumeyer J., Jakob M., Hallas C., Tchikov V., Winoto-Morbach S., Wickel M., Schneider-Brachert W., Trauzold A., Hethke A., and Schutze S. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ. 11 (2004) 550-563
87. Yeung B.H., Huang D.C., and Sinicrope F.A. PS-341 (bortezomib) induces lysosomal cathepsin B release and a caspase-2-dependent mitochondrial permeabilization and apoptosis in human pancreatic cancer cells. J. Biol. Chem. 281 (2006) 11923-11932
88. Baumgartner H.K., Gerasimenko J.V., Thorne C., Ashurst L.H., Barrow S.L., Chvanov M.A., Gillies S., Criddle D.N., Tepikin A.V., Petersen O.H., Sutton R., Watson A.J., and Gerasimenko O.V. Caspase-8-mediated apoptosis induced by oxidative stress is independent of the intrinsic pathway and dependent on cathepsins. Am. J. Physiol.: Gastrointest. Liver Physiol. 293 (2007) G296-G307
89. Brunk U.T., and Svensson I. Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Rep. 4 (1999) 3-11
90. Werneburg N.W., Guicciardi M.E., Bronk S.F., Kaufmann S.H., and Gores G.J. Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins. J. Biol. Chem. 282 (2007) 28960-28970
91. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 8 (2001) 569-581
92. Maiuri M.C., Zalckvar E., Kimchi A., and Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev., Mol. Cell Biol. 8 (2007) 741-752
93. Levine A.J., Hu W., and Feng Z. The P53 pathway: what questions remain to be explored?. Cell Death Differ. 13 (2006) 1027-1036
94. Michalovitz D., Halevy O., and Oren M. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62 (1990) 671-680
95. Yuan X.M., Li W., Dalen H., Lotem J., Kama R., Sachs L., and Brunk U.T. Lysosomal destabilization in p53-induced apoptosis. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6286-6291
96. Chen W., Li N., Chen T., Han Y., Li C., Wang Y., He W., Zhang L., Wan T., and Cao X. The lysosome-associated apoptosis-inducing protein containing the pleckstrin homology (PH) and FYVE domains (LAPF), representative of a novel family of PH and FYVE domain-containing proteins, induces caspase-independent apoptosis via the lysosomal-mitochondrial pathway. J. Biol. Chem. 280 (2005) 40985-40995
97. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 211 (1956) 298-300
98. Barja G. Free radicals and aging. Trends Neurosci. 27 (2004) 595-600
99. Lane N. Power, Sex, Suicide: Mitochondria and the Meaning of Life (2005), Oxford University Press, Oxford 289-301
100. Ku H.H., Brunk U.T., and Sohal R.S. Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. Free Radic. Biol. Med. 15 (1993) 621-627
101. Ghadially F.N. Ultrastructural Pathology of the Cell and Matrix. Second ed., (1975), Butterworths, London
102. Fattoretti P., Bertoni-Freddari C., Casoli T., Di Stefano G., Solazzi M., and Corvi E. Morphometry of age pigment (lipofuscin) and of ceroid pigment deposits associated with vitamin E deficiency. Arch. Gerontol. Geriatr. 34 (2002) 263-268
103. Wenger D.A., Coppola S., and Liu S.L. Insights into the diagnosis and treatment of lysosomal storage diseases. Arch. Neurol. 60 (2003) 322-328
104. Cao Y., Espinola J.A., Fossale E., Massey A.C., Cuervo A.M., MacDonald M.E., and Cotman S.L. Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J. Biol. Chem. 281 (2006) 20483-20493
105. Elleder M., Sokolova J., and Hrebicek M. Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders. Acta Neuropathol. (Berl) 93 (1997) 379-390
106. Lee F.Y., Lee T.S., Pan C.C., Huang A.L., and Chau L.Y. Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis 138 (1998) 281-288
107. Nilsson S.E., Sundelin S.P., Wihlmark U., and Brunk U.T. Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage. Doc. Ophthalmol. 106 (2003) 13-16
108. Brun A., and Brunk U. Heavy metal localization and age related accumulation in the rat nervous system. A histochemical and atomic absorption spectrophotometric study. Histochemie 34 (1973) 333-342
109. Terman A., Dalen H., and Brunk U.T. Ceroid/lipofuscin-loaded human fibroblasts show decreased survival time and diminished autophagocytosis during amino acid starvation. Exp. Gerontol. 34 (1999) 943-957
110. Cuervo A.M., and Dice J.F. When lysosomes get old. Exp. Gerontol. 35 (2000) 119-131
111. Terman A., and Brunk U.T. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc. Res. 68 (2005) 355-365
112. Terman A., and Brunk U.T. Oxidative stress, accumulation of biological 'garbage', and aging. Antioxid. Redox Signal. 8 (2006) 197-204
113. Navratil M., Terman A., and Arriaga E.A. Giant mitochondria do not fuse and exchange their contents with normal mitochondria. Exp. Cell Res. 314 (2008) 164-172
114. Stadtman E.R., Starke-Reed P.E., Oliver C.N., Carney J.M., and Floyd R.A. Protein modification in aging. EXS 62 (1992) 64-72
115. Rattan S.I. Synthesis, modifications, and turnover of proteins during aging. Exp. Gerontol. 31 (1996) 33-47
116. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
117. Bennett M.C. The role of alpha-synuclein in neurodegenerative diseases. Pharmacol. Ther. 105 (2005) 311-331
118. Li W., Dalen H., Eaton J.W., and Yuan X.M. Apoptotic death of inflammatory cells in human atheroma. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1124-1130
119. Li W., Ostblom M., Xu L.H., Hellsten A., Leanderson P., Liedberg B., Brunk U.T., Eaton J.W., and Yuan X.M. Cytocidal effects of atheromatous plaque components: the death zone revisited. FASEB J. 20 (2006) 2281-2290
120. Yu W.H., Cuervo A.M., Kumar A., Peterhoff C.M., Schmidt S.D., Lee J.H., Mohan P.S., Mercken M., Farmery M.R., Tjernberg L.O., Jiang Y., Duff K., Uchiyama Y., Naslund J., Mathews P.M., Cataldo A.M., and Nixon R.A. Macroautophagy-a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 171 (2005) 87-98
121. Zheng L., Roberg K., Jerhammar F., Marcusson J., and Terman A. Autophagy of amyloid beta-protein in differentiated neuroblastoma cells exposed to oxidative stress. Neurosci. Lett. 394 (2006) 184-189
122. Gouras G.K., Almeida C.G., and Takahashi R.H. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol. Aging 26 (2005) 1235-1244
123. Lee S.T., and Kim M. Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington's disease. Mech. Ageing Dev. 127 (2006) 432-435